AI drug developer Absci partners with Oracle and AMD

2025-09-11 21:25:27

Absci, an AI drug developer, announced a collaboration with Oracle and AMD to accelerate generative AI-driven drug discovery. The company's drug discovery platform will leverage Oracle's AI infrastructure and AMD's latest hardware.

Oracle AI AI AMD

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Musk: XAI will certainly raise funds in the next few months, but not now
                            2025-09-20

                                    Nvidia (NVDA.O) fell further, dropping nearly 3%.
                            2025-09-17

                                    SoftBank and OpenAI's AI joint venture in Japan is severely delayed, with an update now expected in November.
                            2025-09-18

                                    Alipay's two operating entities have completed the name change
                            2025-09-19

                                    Hande Information: The company has cooperation with Oracle
                            2025-09-23